Uterine sarcoma, version 1.2016 Journal Article
| Authors: | Koh, W. J.; Greer, B. E.; Abu-Rustum, N. R.; Apte, S. M.; Campos, S. M.; Cho, K. R.; Chu, C.; Cohn, D.; Crispens, M. A.; Dizon, D. S.; Dorigo, O.; Eifel, P. J.; Fisher, C. M.; Frederick, P.; Gaffney, D. K.; George, S.; Han, E.; Higgins, S.; Huh, W. K.; Lurain, J. R. 3rd; Mariani, A.; Mutch, D.; Fader, A. N.; Remmenga, S. W.; Reynolds, R. K.; Tillmanns, T.; Valea, F. A.; Yashar, C. M.; McMillian, N. R.; Scavone, J. L. |
| Article Title: | Uterine sarcoma, version 1.2016 |
| Abstract: | The NCCN Guidelines for Uterine Neoplasms provide interdisciplinary recommendations for treating endometrial carcinoma and uterine sarcomas. These NCCN Guidelines Insights summarize the NCCN Uterine Neoplasms Panel's 2016 discussions and major guideline updates for treating uterine sarcomas. During this most recent update, the panel updated the mesenchymal tumor classification to correspond with recent updates to the WHO tumor classification system. Additionally, the panel revised its systemic therapy recommendations to reflect new data and collective clinical experience. These NCCN Guidelines Insights elaborate on the rationale behind these recent changes. © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. |
| Keywords: | histopathology; review; doxorubicin; cancer combination chemotherapy; systemic therapy; gemcitabine; cancer adjuvant therapy; temozolomide; antineoplastic agent; endometrium carcinoma; dacarbazine; aromatase inhibitor; estrogen; evidence based practice; practice guideline; ifosfamide; docetaxel; cancer hormone therapy; professional practice; pazopanib; tamoxifen; epirubicin; mesenchymal stem cell; accreditation; world health organization; continuing education; trabectedin; navelbine; personal experience; decision making; tumor classification; uterus sarcoma; hormone sensitivity; megestrol acetate; eribulin; medroxyprogesterone acetate; gestagen; randomized controlled trial (topic); phase 2 clinical trial (topic); megestrol; meta analysis (topic); phase 3 clinical trial (topic); tumor immunology; progesterone; nursing education; medroxyprogesterone; systematic review (topic); cancer prognosis; human; prognostic assessment |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 13 |
| Issue: | 11 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2015-11-01 |
| Start Page: | 1321 |
| End Page: | 1331 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 26553763 |
| DOI/URL: | |
| Notes: | Export Date: 2 December 2015 -- Source: Scopus |
